Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score

BJU International

Volumn 107, Issue 10, 2011, Pages 1562-1569

  Huang, Ying ^a   Isharwal, Sumit ^b   Haese, Alexander ^c   Chun, Felix K H ^c   Makarov, Danil V ^d   Feng, Ziding ^e   Han, Misop ^f   Humphreys, Elizabeth ^f   Epstein, Jonathan I ^f   Partin, Alan W ^f   Veltri, Robert W ^f  

^a Department of Medicine   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e USA   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

nomogram; outcome; partin tables; pathological stage; predictiveness curve; prostate cancer

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SEMINAL VESICLE; TUMOR BIOPSY;

BIOPSY; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 79955412343     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09692.x     Document Type: Article

References (26)

1. Baade PD, Youlden DR, Krnjacki LJ,. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009; 53: 171-84
2. Gerber GS, Thisted RA, Scardino PT, et al,. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 1996; 276: 615-9 (Pubitemid 26278066)
3. Campbell MF, Wein AJ, Kavoussi LR,. Campbell-Walsh Urology. Editor-in-chief, Alan J. Wein; editors, Louis R. Kavoussi. [et al.], 9th edn. Philadelphia: W.B. Saunders, 2007
4. Partin AW, Yoo J, Carter HB, et al,. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993; 150: 110-4 (Pubitemid 23175983)
5. Partin AW, Kattan MW, Subong EN, et al,. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277: 1445-51 (Pubitemid 27208886)
6. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD,. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58: 843-8 (Pubitemid 34017254)
7. Makarov DV, Trock BJ, Humphreys EB, et al,. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007; 69: 1095-101 (Pubitemid 46891611)
8. Kattan MW, Stapleton AM, Wheeler TM, Scardino PT,. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer 1997; 79: 528-37 (Pubitemid 27051778)
9. Veltri RW, Miller MC, Partin AW, Poole EC, O'Dowd GJ,. Prediction of prostate carcinoma stage by quantitative biopsy pathology. Cancer 2001; 91: 2322-8 (Pubitemid 32552818)
10. Haese A, Chaudhari M, Miller MC, et al,. Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study. Cancer 2003; 97: 969-78 (Pubitemid 36173147)
11. Ohori M, Kattan MW, Koh H, et al,. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 2004; 171: 1844-9 (Pubitemid 38501019)
12. Koh H, Kattan MW, Scardino PT, et al,. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 2003; 170: 1203-8 (Pubitemid 37108113)
13. Cagiannos I, Karakiewicz P, Eastham JA, et al,. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003; 170: 1798-803 (Pubitemid 37254931)
14. Karakiewicz PI, Bhojani N, Capitanio U, et al,. External validation of the updated Partin tables in a cohort of North American men. J Urol 2008; 180: 898-902; discussion -3
15. Yu JB, Makarov DV, Sharma R, Peschel RE, Partin AW, Gross CP,. Validation of the partin nomogram for prostate cancer in a national sample. J Urol 2010; 183: 105-11
16. Huang Y, Sullivan Pepe M, Feng Z,. Evaluating the predictiveness of a continuous marker. Biometrics 2007; 63: 1181-8 (Pubitemid 350212578)
17. Epstein JI,. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am J Surg Pathol 2000; 24: 477-8 (Pubitemid 30180740)
18. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC,. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555-65 (Pubitemid 32916759)
19. Haqq C, Li R, Khodabakhsh D, et al,. Ethnic and racial differences in prostate stromal estrogen receptor alpha. Prostate 2005; 65: 101-9 (Pubitemid 41362276)
20. Hoffman RM, Gilliland FD, Eley JW, et al,. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2001; 93: 388-95 (Pubitemid 32229383)
21. Oakley-Girvan I, Feldman D, Eccleshall TR, et al,. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiol Biomarkers Prev 2004; 13: 1325-30 (Pubitemid 39071556)
22. Heath EI, Kattan MW, Powell IJ, et al,. The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. Urology 2008; 71: 151-5 (Pubitemid 351173254)
23. Karakiewicz PI, Hutterer GC,. Predictive models and prostate cancer. Nat Clin Pract Urol 2008; 5: 82-92 (Pubitemid 351248097)
24. Wang L, Hricak H, Kattan MW, et al,. Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology 2007; 242: 182-8 (Pubitemid 44956023)
25. De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI,. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology 1999; 53: 707-13 (Pubitemid 29163034)
26. Karam JA, Svatek RS, Karakiewicz PI, et al,. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. Clin Cancer Res 2008; 14: 1418-22 (Pubitemid 351413924)